The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Neuropsychiatric symptoms and quality of life in Spanish patients with Alzheimer’s disease during the COVID‐19 lockdown
Open accessAbstract
BACKGROUND AND PURPOSE: The COVID-19 epidemic is affecting almost all individuals worldwide, and patients with Alzheimer's disease (AD) and amnesic mild cognitive impairment (MCI) are particularly at risk due to their characteristics and age. We analysed the impact of the pandemic on these patients' neuropsychiatric symptoms and their quality of life after 5 weeks of lockdown in Spain. METHODS: A total of 40 patients with a diagnosis of MCI (n = 20) or mild AD (n = 20) from the Cognitive Stimulation Program of the Cognitive Disorders Unit were evaluated. All patients had undergone a previous evaluation during the month before the lockdown, and were re-evaluated after 5 weeks of lockdown. The Neuropsychiatric Inventory (NPI) and EuroQol-5D questionnaire (EQ-5D) were used to assess neuropsychiatric symptoms in patients and the quality of life in patients as well in caregivers. RESULTS: The mean (SD) total baseline NPI score was 33.75 (22.28), compared with 39.05 (27.96) after confinement (P = 0.028). The most frequently affected neuropsychiatric symptoms were apathy [4.15 (3.78) vs. 5.75 (4.02); P = 0.002] and anxiety [3.95 (3.73) vs. 5.30 (4.01); P = 0.006] in patients with MCI, and apathy [2.35 (2.70) vs. 3.75 (3.78); P = 0.036], agitation [0.45 (1.14) vs. 1.50 (2.66); P = 0.029] and aberrant motor behaviour [1.25 (2.86) vs. 2.00 (2.93); P = 0.044] in patients with AD. We did not observe differences in EQ-5D scores during the re-evaluation. The 30% of patients and 40% of caregivers reported a worsening of the patients' health status during confinement. CONCLUSIONS: The results of this study show the worsening of neuropsychiatric symptoms in patients with AD and MCI during 5 weeks of lockdown, with agitation, apathy and aberrant motor activity being the most affected symptoms.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Lara et al. (26) observed that comparable changes, especially in apathy, occurred in both patients with mild cognitive impairment, and dementia due to AD.”
From The impact of COVID-19 infection and enforced prolonged social isolation on neuropsychiatric symptoms in older adults with and without dementia: A review (2020) · cites this paper as [26]
In the citing paper
“The majority of these studies included standardised tools to assess the presence and severity of neuropsychiatric symptoms, mostly the Neuropsychiatric Inventory (NPI) (23, 26, 27).”
From The impact of COVID-19 infection and enforced prolonged social isolation on neuropsychiatric symptoms in older adults with and without dementia: A review (2020) · cites this paper as [26]
In the citing paper
“although changes in symptom severity were found to be similar between patients with mild cognitive impairment and dementia (26).”
From The impact of COVID-19 infection and enforced prolonged social isolation on neuropsychiatric symptoms in older adults with and without dementia: A review (2020) · cites this paper as [26]
Citations
Cites
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · PubMed · Cited by 21,012
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.008 · Cited by 10,152 · cited 12×
“The COVID epidemic is affecting individuals worldwide, and Alzheimer’s disease (AD) and amnesic mild cognitive impairment (MCI) patients are at risk due to their characteristics and age.”
MethodInfluentialThe Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia
Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994) · Neurology · doi:10.1212/wnl.44.12.2308 · Cited by 7,568 · cited 1×
“The NPI concerns the severity and frequency of the following 12 domains of behavioural functioning: delusions, hallucinations, agitation/aggression, dysphoria, anxiety, euphoria, apathy, disinhibition, irritability/lability, aberrant motor activity, night-time behavioural disturbances, and appetite and eating abnormal…”
BackgroundOutbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle
Lu, H., Stratton, C. W., & Tang, Y. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25678 · Cited by 3,497
Ho, C. S., Chee, C. Y., & Ho, R. C. (2020) · Annals of the Academy of Medicine, Singapore · doi:10.47102/annals-acadmedsg.202043 · Cited by 1,699
Ho, C. S. H., Chee, C. Y., & Ho, R. (2020) · PubMed · Cited by 1,354
Troyer, E. A., Kohn, J. N., & Hong, S. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.04.027 · Cited by 964
COVID ‐19 and Older Adults: What We Know
Shahid, Z., Kalayanamitra, R., McClafferty, B., Kepko, D., Ramgobin, D., Patel, R. J., Aggarwal, C. S., Vunnam, R., Sahu, N., Bhatt, D., et al. (2020) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16472 · Cited by 958
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–196 of 196
Geschke, K., Palm, S., Fellgiebel, A., & Wuttke, A. (2021) · GeroPsych · doi:10.1024/1662-9647/a000273 · Cited by 7
Early Impact of the COVID-19 Pandemic on Outpatient Neurologic Care in Hawai'i.
Crocker, J., Liu, K., Smith, M., Nakamoto, M., Mitchell, C., Zhu, E., Ma, E., Morden, F. T. C., Chong, A., Van, N., et al. (2022) · PubMed Central · Cited by 5
Yuan, S., Zhang, W., Yao, Q., Lü, W., Yu, W., Zhong, F., Wang, Y., Xing, D., Wang, X., Song, J., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.762907 · Cited by 5
Can COVID-19 pandemic worsen previous neurological/psychiatric diseases?
Fleury, A., Río‐Quiñones, M. A. D., Aguirre‐Cruz, L., Toledo, A., Murrieta, I., Santiago, K., Uribe, E., Miranda, L. H. L., Toledo, V., Soto, W., et al. (2022) · Neurology Perspectives · doi:10.1016/j.neurop.2022.06.002 · Cited by 5
Gramegna, A., Mantero, M., Amati, F., Aliberti, S., & Blasi, F. (2021) · European Respiratory Society eBooks · doi:10.1183/2312508x.10024420 · Cited by 5
Çınar, N. (2022) · SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital · doi:10.14744/semb.2022.40326 · Cited by 5
“showed that the most frequent neuropsychiatric symptoms in patients with dementia were agitation, apathy, and aberrant motor activity during the 5 weeks of lockdown.[28]”
BackgroundMoitra, S., Anderson, A., Eathorne, A., Brickstock, A., Adán, A., Akgün, M., Tabrizi, A. F., Haldar, P., Henderson, L., Jindal, S. K., et al. (2023) · Journal of Global Health · doi:10.7189/jogh.13.06045 · Cited by 5
Telemedicine in French Memory Clinics During the COVID-19 Pandemic
Morin, A., Pressat-Laffouilhere, T., Sarazin, M., Lagarde, J., Roue-Jagot, C., Olivieri, P., Paquet, C., Cognat, E., Dumurgier, J., Pasquier, F., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215459 · Cited by 4
Sánchez-García, M., Rey, T. R.-D., Pérez, E., & Gay-Puente, F. J. (2022) · Revista de Neurología · doi:10.33588/rn.7403.2021356 · Cited by 5
Braga, R., & Castaño, E. F. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192315511 · Cited by 4
“As for those with a serious affectation, other aspects need to be considered to explain this result, since they contradict the proposed hypothesis and the results found in research into persons with dementia [13,24].”
BackgroundResultSayed, L., Alanazi, M. O., & Ajrouch, K. J. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20115918 · Cited by 4
Frailty and senile apathy in the everyday clinical practice in the conditions of COVID-19
Veselova, D. К., & Викторович, Б. В. (2022) · Journal of clinical practice · doi:10.17816/clinpract104831 · Cited by 4
“Апатия у пожилых людей во время пандемии развивается часто, но главным образом у пациентов с пограничными нервно-психическими расстройствами [100] и болезнью Альцгеймера [101].”
Gamble, L. D., Parker, S., Quinn, C., Bennett, H., Martyr, A., Sabatini, S., Pentecost, C., Collins, R., Dawson, E., Hunt, A., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220221 · Cited by 4
“Meanwhile, other studies found no significant changes in carers’ anxiety, well-being, quality of life, or distress [26, 27].”
Mousazadeh, H. (2022) · Quaestiones Geographicae · doi:10.14746/quageo-2022-0043 · Cited by 4
“COVID-19 has spread globally and swiftly with major impacts on the QOL of people (Lara et al. 2020; Khan et al. 2021), and the resulting quarantine has destroyed our SOP (Riva, Wiederhold 2020).”
Nawaz, A. D., Haider, M. Z., & Akhtar, S. (2023) · Biomolecules and Biomedicine · doi:10.17305/bb.2023.9680 · Cited by 4
“As a result, patients with Alzheimer’s disease reported worsening mood symptoms, such as loneliness, depression, hallucinations, anxiety, agitation, and aberrant motor behavior along with cognitive defects, such as memory loss and compromised recall ability [47, 64, 66–68, 70, 85, 86].”
BackgroundWurm, R., Parvizi, T., Silvaeih, S., Berger–Sieczkowski, E., Goeschl, S., König, T., Lehrner, J. P., & Stögmann, E. (2022) · Clinical Medicine · doi:10.7861/clinmed.2021-0605 · Cited by 4
Jiménez, E. M. F., Zavala-Calahorrano, A., & Aguilar-Salazar, A. F. (2023) · Medwave · doi:10.5867/medwave.2023.01.2592 · Cited by 4
Puit, J. K. D., & Challinor, K. L. (2025) · Journal of Aging Research · doi:10.1155/jare/9924448 · Cited by 3
Chen, Y. S., Mollayeva, T., Fitzpatrick, R. L., Sant’Ana, T. T., Farina, F. R., Swiatek, D., Sopidou, K., Tabilo, E., Betka, M. M., Leroi, I., et al. (2025) · Brain and Behavior · doi:10.1002/brb3.71100 · Cited by 4
“…et al. 2021; Helvaci Yilmaz et al. 2021; Penteado et al. 2020; Manca et al., 2021; Cohen et al. 2020a; Azevedo et al. 2021; Yuan et al. 2021; Yuan et al. 2022; Wei et al. 2022; Russo et al. 2021; van Maurik et al. 2020; Kuroda et al. 2022; Lara et al. 2020; Manini et al. 2021; Giebel et al. 2021).”
Defrancesco, M., Hofer, A., & Schurr, T. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1340498 · Cited by 4
Paggetti, A., Lorenzini, P., Fabrizi, E., Nolfi, A. D., Zambri, F., Giusti, A., Palermo, V., Palazzesi, I., Passoni, S., Camilli, F., et al. (2025) · Psychogeriatrics · doi:10.1111/psyg.70081 · Cited by 3
“In line with this, evidence reported increased BPSD during lock-down, in particular aggression, anxiety, agitation, and apathy [30, 31], and also reported a worsening of psychotic symptoms [32].”
COVID-associated cognitive impairments: A review
Preobrazhenskaya, I. S. (2022) · Consilium Medicum · doi:10.26442/20751753.2022.2.201512 · Cited by 3
“[47] провели исследование, в котором показали, что более выраженная апатия, возбуждение, агрессия и аберрантное моторное поведение отмечались у пациентов с легкими КН и деменцией при БА в условиях пандемии COVID-19, вне зависимости от наличия или отсутствия инфицирования вирусом SARS-CoV-2.”
Nora, C. D., de Lima, J. D., Teixeira, I. A., Silva, F. D. O., de Almeida, J. S., Monteiro, F. C., Marinho, V., Dourado, M. C. N., & Deslandes, A. C. (2022) · Dementia & Neuropsychologia · doi:10.1590/1980-5764-dn-2021-0079 · Cited by 3
Assessment of COVID-19 lockdown effect on early Alzheimer Disease progression
Peña‐Bautista, C., Álvarez‐Sánchez, L., Ferrer, I., García, L., Baquero, M., & Cháfer‐Pericás, C. (2023) · Journal of Neurology · doi:10.1007/s00415-023-11899-5 · Cited by 3
“Recently, most of the studies are focused on the status of AD patients during the period of lockdown, which was a period of high uncertainty for the entire population [34].”
BackgroundInfluentialMukherjee, R., Bhattacharyya, B., Mukherjee, A., Das, G., Das, S., & Biswas, A. (2022) · Dementia & Neuropsychologia · doi:10.1590/1980-5764-dn-2021-0100 · Cited by 3
Exercise: a narrative review of mechanism and dosage as an antidepressant
Ganjeh, S., Roostayi, M. M., Daryabor, A., Kalantari, K. K., & Rezaeian, Z. S. (2025) · Physical Therapy Reviews · doi:10.1080/10833196.2025.2496862 · Cited by 2
Perdixi, E., Bernini, S., Conti, S., Jesuthasan, N., Ramusino, M. C., Costa, A. C., & Prinelli, F. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.995308 · Cited by 2
“Three studies conducted during the lockdown in 2020 among patients (11, 12) and community-dwelling (13) older seniors with pre-existing neurocognitive disorders showed worsening neuropsychiatric traits, such as anxiety, agitation and apathy that reduce flexibility and coping abilities.”
BackgroundEpidemiološke ocene prevalence demence v Sloveniji
Lovrečić, B., & Lovrečić, M. (2022) · ZRC SAZU, Založba ZRC eBooks · doi:10.3986/9789610506966_01 · Cited by 2
Impactos da Covid-19 na qualidade de vida de pessoas com Alzheimer: uma revisão integrativa
Fontenele, A. R. B., Cunha, K. R. F., Brandão, R. N., Carreiro, L. E. A. R., Neto, A. L. D. C., Gonçalves, F. M. D. S., Fontinele, A. D. S., Lustosa, T. R. A., Resende, A. K. M., & Barbosa, N. S. (2023) · Revista Eletrônica Acervo Saúde · doi:10.25248/reas.e11563.2023 · Cited by 2
Collins, R., Dawson, E., Pentecost, C., Stapley, S., Quinn, C., Charlwood, C., Allan, L. M., Victor, C. R., & Clare, L. (2023) · International Journal of Care and Caring · doi:10.1332/239788223x16893442145108 · Cited by 2
Brown, M. J., Adkins‐Jackson, P. B., Sayed, L., Wang, F. “., Leggett, A. N., & Ryan, L. H. (2023) · Journal of Aging and Health · doi:10.1177/08982643231223555 · Cited by 2
“…such as social distancing, led to social isolation and loneliness, which likely increased the risk of developing depression and anxiety (Borelli et al., 2021; Borges-Machado et al., 2020; Coin et al., 2021; Di Santo et al., 2020; Gedde et al., 2022; Lara et al., 2020; Pongan et al., 2021).”
Zhu, A. Y. F., & Chou, K. (2024) · Current Psychology · doi:10.1007/s12144-023-05601-1 · Cited by 3
“However, most of the previous research relied on cross-sectional samples, and only a few studies compared mental health before and during the pandemic (Berthelot et al., 2020; Lara et al., 2020).”
Du, J.-M., Burger, H., Kupers, T., Sulim, K., Homburg, M., Muris, J., Hartman, T. O., Zuidema, S., Peters, L., & Janus, S. I. M. (2024) · BMC Geriatrics · doi:10.1186/s12877-024-04708-9 · Cited by 2
“At the beginning of the pandemic in 2020, CD-Old-erPwD experienced deterioration of neuropsychiatric symptoms (NPSs) and cognitive functions [7, 9–13].”
BackgroundSeptal panniculitis as manifestation of COVID-19: own data
Egorova, O. N., Goloeva, R., & Abdulganieva, D. I. (2021) · Modern Rheumatology Journal · doi:10.14412/1996-7012-2021-4-31-37 · Cited by 2
Dong, W., Xu, J. B., Wu, Z., Liu, Y., Zhou, Y., Li, J., Wang, S., Dong, X., Saripan, M. I., & Song, H. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.827273 · Cited by 2
“…as the COVID-19 pandemic intensified, patients with cognitive impairment were limited in going out for rehabilitation training, which had many negative effects on the mental state of patients and his mental condition was deteriorating (Lara et al., 2020; Manca et al., 2020; Devita et al., 2021).”
BackgroundKarpenko, O., Syunyakov, T., Osipova, N. G., Savilov, V., Kurmyshev, M. V., & Kostyuk, G. P. (2022) · Annals of the Russian academy of medical sciences · doi:10.15690/vramn1650 · Cited by 2
Neuropsychiatric complications from COVID-19
Solano, J. G. G., & Bernita, R. E. S. (2022) · Salud Ciencia y Tecnología · doi:10.56294/saludcyt2022223 · Cited by 2
Bombón-Albán, P. E., & Salazar, J. V. S. (2022) · Revista de Neuro-Psiquiatría · doi:10.20453/rnp.v85i2.4229 · Cited by 2
Defrancesco, M., Deisenhammer, E., Schurr, T. A., & Ortner, M. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-220887 · Cited by 2
Choi, J., Koo, B., Seo, W. S., Cheon, E., Sung, H. M., Kim, J. Y., Jeong, H.-S., Kim, Y., & Kim, H.-G. (2023) · Psychiatry Investigation · doi:10.30773/pi.2022.0223 · Cited by 1
Global trends in COVID-19 Alzheimer's related research: a bibliometric analysis
Cao, C., Li, S., Zhou, G., Xu, C., Chen, X., Qiu, H., Li, X., Liu, Y., Cao, H., & Bi, C. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1193768 · Cited by 2
“One paper described the impact of SARS-CoV-2 on neuropsychiatric symptoms and quality of life in patients with AD (19).”
BackgroundInfluentialRamírez-Coronel, A., Cevasco, J., Londra, F., & Saux, G. (2024) · European Journal of Psychology of Education · doi:10.1007/s10212-024-00850-5 · Cited by 1
Effect of Socialization on Alzheimer’s Disease During the COVID-19 Pandemic
Maldonado-Puebla, R. A., Raina, P. M., & Khanna, D. (2024) · Cureus · doi:10.7759/cureus.66942 · Cited by 1
“Lara et al. (2020) found that neuropsychiatric symptoms worsened during the pandemic due to social isolation and that the symptoms most affected were agitation, apathy, and aberrant motor activity [47].”
BackgroundYoon, J. M., Kim, E., & Trinkoff, A. M. (2024) · BMC Geriatrics · doi:10.1186/s12877-024-05563-4 · Cited by 1
“The increase in antidepressant use coincides with an increased prevalence of depression, apathy, and agitation during the pandemic [46, 51, 53, 54].”
Brito, L., Leite, Â. M. T., & Pereira, M. G. (2025) · Clínica y Salud · doi:10.5093/clh2025a11 · Cited by 1
The Effects of Covid-19 Lockdown on Persons with Dementia
Grkman, L., Lovrečić, B., & Lovrečić, M. (2022) · Collegium Antropologicum · doi:10.5671/ca.46.4.6 · Cited by 1
Unraveling the Effects of SARS-CoV-2 on Dementia: A Comprehensive Study
Kadiri, S. K., & Tiwari, P. K. (2024) · Coronaviruses · doi:10.2174/0126667975329888241010115929 · Cited by 1
Moon, J., Lee, K., Sung, H. K., & Kim, S. (2025) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.70100 · Cited by 1
“Previous studies reported significant reductions in memory function, increased depression and anxiety, and exacerbated behavioral symptoms during extended periods of isolation, both of which are known risk factors for dementia [30, 31].”
Sood, A., Goyal, R., Singh, H., Behl, T., Arora, S., Saini, B., & Kaur, R. (2021) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527320666210820092817 · Cited by 1
Dominke, C., Wei, G., Piguet, O., Kumfor, F., & Diehl‐Schmid, J. (2021) · Nervenheilkunde · doi:10.1055/a-1548-4602 · Cited by 1
O impacto do coronavírus na doença de Alzheimer: uma revisão narrativa
da Rocha, J. C. P., Melo, G. D. O., Cardoso, V. N. D. S., da França, G. S., Silva, G. D. O., & Gentil, V. N. (2021) · Revista Eletrônica Acervo Saúde · doi:10.25248/reas.e8470.2021 · Cited by 1
Giebel, C. M., Lion, K., Lorenz‐Dant, K., Gonzalez, A. S., Talbot, C. V., Wharton, E., Cannon, J., Tetlow, H., & Thyrian, J. R. (2022) · Research Square · doi:10.21203/rs.3.rs-1317615/v1 · Cited by 1
Neurological impairments in COVID-19 pandemic
Bjelobaba, I. M., & Kanazir, S. (2020) · Hrana i ishrana · doi:10.5937/hraish2002071b
“In fact, a small Spanish study recorded a significant worsening of symptoms among patients with Alzheimer’s disease (AD) and mild cognitive impairment [69].”
BackgroundMaćkowiak, M., Senczyszyn, A., Lion, K., Trypka, E., Małecka, M., Ciułkowicz, M., Mazurek, J., Świderska, R., Giebel, C. M., Gabbay, M., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-415217/v1
COVID-19 - O VÍRUS QUE MOVIMENTOU A CIÊNCIA - VOLUME 2
Duarte, F. B., Dutra, A. P. B. S., de Freitas, G. V., Fukuoka, V. M., Guimarães, L. F., Moeller, A. G., de Oliveira, F., Paz, A. A., Seroiska, G., da Silva, A. L., et al. (2021) · Editora Pasteur eBooks · doi:10.29327/535425
Gosse, P. J., Kassardjian, C. D., Masellis, M., & Mitchell, S. B. (2021) · Canadian Medical Association Journal · doi:10.1503/cmaj.201938-f
Неврологические аспекты COVID‑19 и его влияние на формирование деменции у пожилых людей
Вишнева, Е. М., & Веснина, Н. С. (2021) · Естественные и Технические Науки · doi:10.37882/2223-2966.2021.05.07
Editorial_COVID-19 and Geriatric Mental Health: the biopsychosocial aspects
Sousa, A. D., & Rupani, K. (2021) · Indian Journal of Mental Health(IJMH) · doi:10.30877/ijmh.8.1.2021.1-5
Разработка технологии и оценка качества порошков из крупяных шротов
Юрьевна, Е. О. (2012) · Food Processing Techniques and Technology
Dawson, L., Dinh, D., Stub, D., Ahern, S., Bloom, J., Duffy, S., Lefkovits, J., Brennan, A., Reid, C., & Oqueli, E. (2022) · Quality of Life Research · doi:10.1007/s11136-021-03056-0
“Other studies have been limited by small cohort sizes and often no comparative group, showing neutral (inflammatory bowel disease, cancer) [20, 21, 23], mixed (Alzheimer’s) [24], or negative (common variable immuno-deficiency, Parkinson’s disease) [25, 26] impacts of COVID-19 on HRQOL among various disease populations.”
BackgroundIodice, F., Cassano, V., & Rossini, P. M. (2020) · doi:10.21203/rs.3.rs-77758/v1
Neuro-Covid-19 et population gériatrique : quelles particularités ?
Khattab, H., Sikkal, A., Bellakhdar, S., Otmani, H. E., Moutawakil, B. E., & Rafai, M. A. (2022) · NPG. Neurologie, psychiatrie, gériatrie/NPG · doi:10.1016/j.npg.2022.01.005
How Can We Facilitate Psychological Recovery Following the COVID-19 Pandemic?
Datta, S. S., Mukherjee, A., & Maitra, R. (2022) · Springer eBooks · doi:10.1007/978-981-16-8472-2_6
Cognitive impairment in patients with coronavirus infection
Starchina, Y. A., & Kosivtsova, O. V. (2022) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2022-4-96-102
Servaes, S., Lussier, F. Z., Tissot, C., Therriault, J., Bezgin, G., Wang, Y.-T., Stevenson, J., Rahmouni, N., Pallen, V., Elgbeili, G., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1968616/v1
Coronavirus infection and cognitive disorders: possible approaches to treatment with Ginkgo biloba
Koberskaya, N. N., & Yakhno, N. N. (2021) · Hi+Med High Technologies in Medicine · doi:10.55947/2782-4748-2021-68-5-8-14
Dehmiyani, A., Azizi, S., Kazemi-Galougahi, M. H., Dadarkhah, A., & Asgari, A. (2022) · Annals of Military and Health Sciences Research · doi:10.5812/amh-132868
“Another study reported that psychiatric symptoms in people with Alzheimer’s disease increased and significantly worsened five weeks after being infected with COVID-19 (37).”
BackgroundDolgotrajni covid-19/postcovidni sindrom in kognitivne motnje
Lovrečić, B., Lovrečić, M., & Grkman, L. (2022) · ZRC SAZU, Založba ZRC eBooks · doi:10.3986/9789610506966_06
(2022) · ZRC SAZU, Založba ZRC eBooks · doi:10.3986/9789610506966_00
Breme neformalnih oskrbovalcev oseb z demenco v času covida-19
Lovrečić, B., Lovrečić, M., & Mavrič, N. (2022) · ZRC SAZU, Založba ZRC eBooks · doi:10.3986/9789610506966_08
Research Progress on the Impact of Social Isolation on Alzheimer’s Disease
肖, 静. (2022) · Hans Journal of Biomedicine · doi:10.12677/hjbm.2022.124035
Post-COVID-19 manifestations: A study of analyzing symptoms, complications following hospitalization
Kaur, D., Agrawal, K. C., Deep, A., Choudhary, H., Soni, L. K., Saran, R., & Sankhla, V. (2022) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_219_22
Dinamika nevropsihiatričnih simptomov pri osebah z demenco v povezavi s pandemijo in covidom-19
Lovrečić, B., Lovrečić, M., & Grkman, L. (2022) · ZRC SAZU, Založba ZRC eBooks · doi:10.3986/9789610506966_05
Duševno zdravje neformalnih družinskih oskrbovalcev oseb z demenco
Lovrečić, B., Lovrečić, M., & Cizl, M. (2022) · ZRC SAZU, Založba ZRC eBooks · doi:10.3986/9789610506966_07
Javnozdravstveni izzivi demence
Lovrečić, B., Lovrečić, M., Sambt, J., Grkman, L., Simon, M. R., Mavrič, N., Sedlak, S., Jelenc, M., Cizl, M., Kralj, M., et al. (2022) · ZRC SAZU, Založba ZRC eBooks · doi:10.3986/9789610506966 · Cited by 2
Poznavanje demence med splošno javnostjo
Lovrečić, B., Lovrečić, M., & Mavrič, N. (2022) · ZRC SAZU, Založba ZRC eBooks · doi:10.3986/9789610506966_02
Dolgotrajna oskrba ljudi z demenco
Mali, J. (2022) · ZRC SAZU, Založba ZRC eBooks · doi:10.3986/9789610506966_03
Ekonomsko breme demence v Sloveniji glede na rutinske podatkovne zbirke zdravstvenega varstva
Lovrečić, B., Sambt, J., Sedlak, S., & Jelenc, M. (2022) · ZRC SAZU, Založba ZRC eBooks · doi:10.3986/9789610506966_04
The effects of lifestyle in Alzheimer's disease during the COVID-19 pandemic
Ray, S., Khan, S. Y., Khan, S., Ali, K., Gray, Z. C., Manna, P. R., & Reddy, P. H. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-15256-6.00006-4
Defrancesco, M., Hofer, A., & Schurr, T. A. (2023) · Research Square · doi:10.21203/rs.3.rs-3481270/v1
DEMÊNCIA DE ALZHEIMER: DESAFIOS, IMPACTO NOS CUIDADORES INFORMAIS E IMPLICAÇÕES PARA A PRÁTICA
Brito, L., Leite, Â. M. T., & Pereira, M. G. (2023) · Editora Artemis eBooks · doi:10.37572/edart_2911230938 · Cited by 1
Lockdown and Mental Health in Alzheimer’s Disease
Haj, M. E., Boutoleau‐Bretonnière, C., Chapelet, G., Kapogiannis, D., & Ndobo, A. (2023) · GeroPsych · doi:10.1024/1662-9647/a000329
Арьев, А. Л., & Лаптева, Е. С. (2024) · Успехи геронтологии · doi:10.34922/ae.2023.36.6.006
Hossein, M. (2023) · Eötvös Loránd Tudományegyetem · doi:10.15476/elte.2023.055
Palpatzis, E., Akinci, M., & Arenaza‐Urquijo, E. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13681-8.00006-0
Benevides, J. A. S., da Silva, A. G., Alexandre, G. C., & da Fonseca, E. R. (2024) · Research Society and Development · doi:10.33448/rsd-v13i5.45630
Global trends in dementia care research in the context of COVID-19: bibliometric analysis
Gómez-Galán, R., Denche-Zamorano, Á. M., Mendoza-Muñoz, M., Pereira-Payo, D., My works are correct, B. M. I. A. A. I. S. R. L. M. T. I. D. A.-M., & Bermejo, L. M. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1388767 · Cited by 1
Arshad, F., Hurzuk, S., Tiwari, M., Varghese, F. A., Hoskeri, R. M., Paplikar, A., Goyal, S., Dhiren, S. R., Ganeshbhai, P. V., Ansari, M. F., et al. (2024) · Current Alzheimer Research · doi:10.2174/0115672050346469241112115052
Splinter, M. J., Henderson, E. J., Ben‐Shlomo, Y., Darweesh, S. K. L., Sowa, P., Wolters, F. J., Velek, P., Meijerink, H., Bakx, P., Ikram, M. A., et al. (2024) · BMC Neurology · doi:10.1186/s12883-024-03975-8
Zawadzki, N. K., Xie, F., Seabury, S. A., Romley, J. A., Fox, D. S., Gong, C. L., Zawadzki, R. S., Jiao, X., & Gu, N. Y. (2025) · Applied Research in Quality of Life · doi:10.1007/s11482-025-10427-z
“…various nations worldwide to assess HRQoL in the general public, specific disease groups, and healthcare providers during the pandemic (Azizi et al., 2020; Bäuerle et al., 2020; Cohen et al., 2021; Garrigues et al., 2020; Lara et al., 2020; Ping et al., 2020; Tran et al., 2020; Wong et al., 2022).”
Varma, K., Krishnan, J., George, C. V. S., & Haseena, B. A. (2024) · The Journal of Clinical and Scientific Research · doi:10.4103/jcsr.jcsr_17_23
Chen, Y. S., Mollayeva, T., Fitzpatrick, R. L., Sant’Ana, T. T., Farina, F. R., Swiatek, D., Sopidou, K., Tabilo, E., Betka, M. M., Leroi, I., et al. (2025) · HRB Open Research · doi:10.12688/hrbopenres.14202.1
Tytgat, A., Diep, A. N., Flamme, F., Dupas, M.-C., Artois, J., Fory, M., Dandoy, M., Damseaux, F., Garigliany, M., Desmecht, D. J.-M., et al. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823251377732
Du, J., Burger, H., Kupers, T., Sulim, K., Homburg, M., Muris, J. W. M., olde Hartman, T. C., ZUIDEMA, S. U., Peters, L. L., & Janus, S. I. M. (2024) · Figshare · doi:10.6084/m9.figshare.26675282
Tuijt, R., Frost, R., Wilcock, J., Robinson, L. A., Manthorpe, J., Rait, G., & Walters, K. R. (2021) · Figshare · doi:10.6084/m9.figshare.14570251
Metadata
- Authors
- Lara, B., Carnes, A., Dakterzada, F., Benitez, I., & Piñol‐Ripoll, G.
- Affiliations
- Hospital Universitari de Santa Maria (ES)
- Hospital Universitari Arnau de Vilanova (ES)
- Corresponding author
- Piñol‐Ripoll, G.
- Venue
- European Journal of Neurology
- Publisher
- Wiley
- Published
- 2020-06-24
- Volume
- 27
- Issue
- 9
- Pages
- 1744-1747
- ISSN
- 1351-5101 (ISSN-L)
- 1468-1331
- PMC
- PMC7283827
- OpenAlex
- W3026319603
- Cited by
- 197
- References
- 12
- Citations by year
- 2025: 10 · 2024: 18 · 2023: 19 · 2022: 68 · 2021: 60 · 2020: 21
- FWCI
- 30.64
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Journal of Neurology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Repositori ObertUDL (University of Lleida) (acceptedVersion)
- Funders
- Agència de Gestió d'Ajuts Universitaris i de Recerca (FI_B100153, SLT008/18)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Social Sciences › Psychology › Clinical Psychology › COVID-19 and Mental Health
- Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
- Keywords
- Alzheimer's disease, amnestic mild cognitive impairment, neuropsychiatric symptoms, COVID-19 lockdown, quality of life, apathy, anxiety, agitation, caregiver burden, cognitive stimulation, Spain, EuroQol-5D, Neuropsychiatric Inventory, caregiver anxiety
- MeSH terms
- COVID-19, Aged, Aged, 80 and over, Alzheimer Disease, Anxiety, Female, Humans, Male, Neuropsychological Tests, Psychomotor Agitation, Quality of Life, Quarantine, Surveys and Questionnaires, Spain, Apathy, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review